Marcos Gómez-Revuelta

4PUBLICATIONS
9CO-AUTHORS
Adolescent healthToxicology (incl. clinical toxicology)PharmacogenomicsPsychological methodology, design and analysis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 16, 2022
Pattern of long-term weight and metabolic changes after a first episode of psychosis: Results from a 10-year prospective follow-up of the PAFIP program for early intervention in psychosis cohort.

J Vázquez-Bourgon, M Gómez-Revuelta, J Mayoral-van Son

|Jul 27, 2022
Aripiprazole vs Risperidone Head-to-Head Effectiveness in First-Episode Non-Affective-Psychosis: A 3-Month Randomized, Flexible-Dose, Open-Label Clinical Trial.

Lucía Garrido-Sánchez, Marcos Gómez-Revuelta, Víctor Ortiz-García de la Foz

|May 31, 2022
Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis.

Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Marcos Gómez-Revuelta

|Jan 25, 2021
Apnea during slow sub-anaesthetic infusion of intravenous ketamine for treatment-resistant depression.

Marcos Gómez-Revuelta, María Fernández-Rodríguez, Laura Boada-Antón

Pageof 1